مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

226
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

111
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity

Pages

  2165-2172

Abstract

 Purpose: We investigated the clinical significance of chromogranin A (CgA) expression as a neuroendocrine (NE) marker during prostate cancer (PCa) progression, especially as a potential predictor of chemotherapeutic response in castration-resistant PCa (CRPC) patients based on immunohistochemical findings. Materials and Methods: Sixteen CRPC patients who underwent combination (docetaxel/estramustine/ carboplatin; DEC) chemotherapy were retrospectively studied. Immunostaining of CgA was performed using prostate biopsy samples obtained at the initial PCa diagnosis, during androgen deprivation therapy, at the time of CRPC diagnosis, and after 2 cycles of DEC therapy. The positive rate was expressed as the mean percentage of positively stained tumor cells against the total number of tumor cells. Differences in positive rates among the treatment courses were compared using a Mann-Whitney test. Results: The mean percentage of CgA-positive PCa cells increased in a stepwise manner until CRPC development and then significantly decreased after DEC therapy. Subanalysis of CgA at CRPC diagnosis showed a more evident reduction of CgA expression after DEC therapy in patients who also had a high level of CgA as compared to those with a low CgA level (P =. 003). Likewise, longer prostate-specific antigen progression-free survival was related to CRPC and high CgA (P =. 028). Conclusion: NE differentiation of PCa cells is accelerated despite androgen deprivation and reaches a peak at the time of CRPC diagnosis. Although further studies using larger samples are needed, CgA expression in CRPC may be a candidate tissue biomarker to reflect the chemotherapy sensitivity of individual PCa cells.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Mitsui, Yozo, Arichi, Naoko, Hiraki, Miho, Harada, Yuji, Yasumoto, Hiroaki, & Shiina, Hiroaki. (2015). Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity. UROLOGY JOURNAL, 12(3), 2165-2172. SID. https://sid.ir/paper/271036/en

    Vancouver: Copy

    Mitsui Yozo, Arichi Naoko, Hiraki Miho, Harada Yuji, Yasumoto Hiroaki, Shiina Hiroaki. Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity. UROLOGY JOURNAL[Internet]. 2015;12(3):2165-2172. Available from: https://sid.ir/paper/271036/en

    IEEE: Copy

    Yozo Mitsui, Naoko Arichi, Miho Hiraki, Yuji Harada, Hiroaki Yasumoto, and Hiroaki Shiina, “Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity,” UROLOGY JOURNAL, vol. 12, no. 3, pp. 2165–2172, 2015, [Online]. Available: https://sid.ir/paper/271036/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button